Corebridge Financial vs MetLife
CRBG and MET side by side, both in life insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRBG and MET compare
MetLife is the larger company, worth 4.1 times as much as Corebridge Financial ($63.6B against $15.5B).
Corebridge Financial grew revenue faster over the last twelve months (29.5% versus 8.7% for MetLife).
MetLife keeps more of each dollar of sales as profit, with a net margin of 4.6% compared with 4.5% at Corebridge Financial.
Both pay dividends: Corebridge Financial yields 2.8% and MetLife 2.3%.
MetLife scores higher on the StockData Score (7 against 5 for Corebridge Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRBG | MET |
|---|---|---|
| Size and price | ||
| Market cap | $15.5B | $63.6B |
| Share price | $34.81 | $100.02 |
| Change, 1 year | 9.4% | 27.7% |
| Change, 5 years | – | 56.3% |
| Beta (5Y) | 1.20 | 0.87 |
| Employees | 4,800 | 46K |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 2 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | – | 19.2× |
| P/S | 0.8× (better) | 0.8× |
| P/B | 1.5× (better) | 2.3× |
| EV/EBITDA | 7.4× | 5.6× (better) |
| Fair value | – | $61.83 |
| Margin of safety | – | −61.8% |
| Growth | ||
| Revenue growth (TTM) | 29.5% (better) | 8.7% |
| Revenue growth, 5Y average | 4.2% (better) | 2.6% |
| Net income growth (TTM) | – | −15.4% |
| EPS growth (TTM) | – | −11.5% |
| EPS growth, 5Y average | – | −3.7% |
| Profitability | ||
| Operating margin | – | 8.3% |
| Net margin | 4.5% | 4.6% (better) |
| Return on equity | 7.9% | 13.2% (better) |
| Return on invested capital | – | 843% |
| Financial health | ||
| Debt / equity | 0.12 | 0.02 (better) |
| Net debt / EBITDA | 0.39 (better) | −4.09 |
| Altman Z-score | 0.13 | 0.27 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.8% (better) | 2.3% |
| Payout ratio | 52.1% | 41.6% |
| Years of dividend growth | – | 13 |
| Dividend growth, 5Y average | – | 4.3% |
| Buyback yield | 19.6% (better) | 3.8% |
| Shareholder yield | 22.4% (better) | 6.2% |
| Ownership | ||
| Held by institutions | 109% | 76.5% |
| Held by insiders | 45.3% | 16.4% |
| Insider net buying, 12 months | −$2.1B | −$1.7M (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | – | 2.1% |
Go deeper
- CRBG stock overview
- CRBG income statement
- CRBG valuation and score
- MET stock overview
- MET income statement
- MET valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.